nejm semaglutide heart failure treatment for with preserved ejection fraction Semaglutide cardiovascular outcomes align more

10.1016/j.dsx.2023.102834

They are not designed for rapid or extreme weight loss

However, while the twice-daily injections may serve as a deterrent for many patients, they can also make it a particularly suitable option for individuals who experience significant post-meal glucose spikes

A BMI of 30 or higher is considered obese, while a BMI of 40 or higher has been deemed severely obese

Originally developed to treat type 2 diabetes, these drugs are now helping many people lose significant amounts of weight

The study was fielded between July 10 and August 18, 2023, across demographic groups, genders, and health conditions